🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate efficacity and safety of everolimus or (...
Status
Completed
Location
CHU Amiens
Start Date
2009-03
Trial ID
NCT01028092
Treatments Being Tested
The purpose of this study is look at the safety of: * Taking a specific co...
Status
Terminated
Location
University of California, San Francisco
Start Date
2014-12-17
Trial ID
NCT02188719
The disparity between supply and demand for organs has stimulated the devel...
Status
Completed
Location
Hospital do Rim e Hipertensao
Start Date
2013-08
Trial ID
NCT01895049
This study is designed to determine the safety and efficacy of two calcineu...
Status
Unknown
Location
The Christ Hospital
Start Date
2021-04-09
Trial ID
NCT04849533
Treatments Being Tested
The aim of the present study is to evaluate the superiority of photopheresi...
Status
Unknown
Location
Deparment of Nephology and Kidney Transplant
Start Date
2022-08-17
Trial ID
NCT04414735
Treatments Being Tested
Despite the improvement of efficacy results with current immunosuppressive ...
Status
Completed
Location
Hospital do rim e Hipertensao
Start Date
2011-05
Trial ID
NCT01354301
Treatments Being Tested
Patients who undergo a kidney transplant require prolonged therapy with dru...
Status
Completed
Location
California Institute Of Renal Research
Start Date
2015-12-31
Trial ID
NCT02137239
The purpose of this study is to evaluate the safety of using lulizumab pego...
Status
Completed
Location
University of Alabama School of Medicine: Transplantation
Start Date
2019-12-11
Trial ID
NCT04066114
The investigators hypothesized that everolimus-based immunosuppressive ther...
Status
Terminated
Location
National Taiwan University Hospital
Start Date
2011-04
Trial ID
NCT01312064
Treatments Being Tested
This is a 2-year, randomized, multicenter, open-label, 2-arm study evaluati...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-12-03
Trial ID
NCT01950819
Treatments Being Tested